J&J Ebola Shot Languishes, Making Merck Vaccine Only Option

(Bloomberg) -- Johnson & Johnson’s experimental Ebola vaccine sits idle in a Dutch warehouse, ready to help counter the international crisis erupting in Africa -- if authorities decide to use it.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.